American Green (American Green) Debt-to-Revenue : 6.14 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is American Green Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

American Green's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $22.81 Mil. American Green's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.47 Mil. American Green's annualized Revenue for the quarter that ended in Jun. 2023 was $3.79 Mil. American Green's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 was 6.14.

American Green Debt-to-Revenue Historical Data

The historical data trend for American Green's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Green Debt-to-Revenue Chart

American Green Annual Data

Trend

Jun22

Jun23

Debt-to-Revenue

6.14

American Green Semi-Annual Data
	Jun22	Jun23
Debt-to-Revenue	-	6.14

Competitive Comparison of American Green's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, American Green's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Green's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, American Green's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where American Green's Debt-to-Revenue falls into.

American Green Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

American Green's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(22.812	+	0.472)	/	3.793
	=	6.14

American Green's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(22.812	+	0.472)	/	3.793
	=	6.14

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (Jun. 2023) Revenue data.

American Green Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of American Green's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

American Green (American Green) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » American Green Inc (OTCPK:ERBB) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 N Gould Street, Suite R, Sheridan, WY, USA, 82801

Website

https://www.americangreen.com

American Green Inc is a technology company in the medical cannabis industry. It is involved in the business of developing a cultivation facility in Phoenix Arizona for medical marijuana and also owns proprietary dispensing machines and all rights to a line of health supplements.